Alexandre Bonet
Femto St
Besancon, 25000, France
Besancon, 25000, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Synthesis and evaluation of lipoic acid - donepezil hybrids for Alzheimer's disease using a straightforward strategy.
Journal: Bioorganic & medicinal chemistry letters
Published: June 13, 2024
Synthesis of Hantzsch Adducts as Cholinesterases and Calcium Flux inhibitors, Antioxidants and Neuroprotectives.
Journal: International journal of molecular sciences
Published: September 11, 2020
Design, Synthesis and Biological Evaluation of New Antioxidant and Neuroprotective Multitarget Directed Ligands Able to Block Calcium Channels.
Journal: Molecules (Basel, Switzerland)
Published: February 28, 2020
Synthesis and biological assessment of racemic benzochromenopyrimidinetriones as promising agents for Alzheimer's disease therapy.
Journal: Future medicinal chemistry
Published: May 16, 2017
New (benz)imidazolopyridino tacrines as nonhepatotoxic, cholinesterase inhibitors for Alzheimer disease.
Journal: Future medicinal chemistry
Published: May 10, 2017
Tetrahydropyranodiquinolin-8-amines as new, non hepatotoxic, antioxidant, and acetylcholinesterase inhibitors for Alzheimer's disease therapy.
Journal: European journal of medicinal chemistry
Published: July 13, 2016
Synthesis and Biological Evaluation of Benzochromenopyrimidinones as Cholinesterase Inhibitors and Potent Antioxidant, Non-Hepatotoxic Agents for Alzheimer's Disease.
Journal: Molecules (Basel, Switzerland)
Published: February 18, 2016
Imidazopyranotacrines as Non-Hepatotoxic, Selective Acetylcholinesterase Inhibitors, and Antioxidant Agents for Alzheimer's Disease Therapy.
Journal: Molecules (Basel, Switzerland)
Published: January 27, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026